help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SUNYER, J.
Right arrow Articles by MÚÑOZ, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SUNYER, J.
Right arrow Articles by MÚÑOZ, A.

Am. J. Respir. Crit. Care Med., Volume 158, Number 3, September 1998, 851-856

Sex Differences in Mortality of People Who Visited Emergency Rooms for Asthma and Chronic Obstructive Pulmonary Disease

JORDI SUNYER, JOSEP M. ANTÓ, DAVE MCFARLANE, ANTONIA DOMINGO, AURELIO TOBÍAS, MARIA-ANTONIA BARCELÓ, and ALVARO MÚÑOZ

Units of Respiratory and Environmental Research, and Health Services Research, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Catalonia, Spain; and Department of Epidemiology, The Johns Hopkins School of Public Health, Baltimore, Maryland

We assess the sex differences in mortality in a population-based cohort of those Barcelona residents older than 14 yr of age who received emergency room services (ERS) for either chronic obstructive pulmonary disease (COPD) or asthma, during the period from 1985 to 1989. Vital status was followed to the end of 1995. A total of 15,517 individuals, 9,918 males and 5,599 females were included in the study. Asthma was diagnosed in 16% of males and 53% of females. Overall, 50% of males and 30% of females died during the follow-up period. The mortality rates in both males and females who visited emergency rooms for COPD or asthma were significantly higher than the expected rates in the general population. These relative increases in the mortality rates were significantly higher in females than in males for both causes of death, COPD (age-adjusted female/male ratio = 2.39), and asthma (ratio = 3.95). However, survival was better in females than males among individuals in the study. The higher fatality in males than females was observed for all causes of death, all respiratory causes, and COPD (risk ratio among patients with COPD = 0.42, 0.29-0.59, and among patients with asthma = 0.11, 0.02-0.60), but not for asthma. Mortality for asthma was higher in females with a diagnosis of COPD (2.79, 1.52-5.13), but it was not different among individuals in whom asthma was diagnosed (1.02, 0.56-1.87). Greater severity of COPD in males than in females could explain a higher risk of dying for all respiratory causes and COPD in males. The increased risk of asthma death in females may be due to problems of coding the term "asthma" in death certificates. The higher rates in females than in males when comparing with the general population, may be an expression of a greater similarity in risk factors, such as smoking, in our population than in males and females of the general population.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
P. G. Camp and S. M. Goring
Gender and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 686 - 691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Lahm, K. M. Patel, P. R. Crisostomo, T. A. Markel, M. Wang, C. Herring, and D. R. Meldrum
Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E865 - E871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Martinez, G. Foster, J. L. Curtis, G. Criner, G. Weinmann, A. Fishman, M. M. DeCamp, J. Benditt, F. Sciurba, B. Make, et al.
Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1326 - 1334.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Ringbaek, N. Seersholm, and K. Viskum
Standardised mortality rates in females and males with COPD and asthma
Eur. Respir. J., May 1, 2005; 25(5): 891 - 895.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. P. Hersh, D. L. DeMeo, E. Al-Ansari, V. J. Carey, J. J. Reilly, L. C. Ginns, and E. K. Silverman
Predictors of Survival in Severe, Early Onset COPD
Chest, November 1, 2004; 126(5): 1443 - 1451.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Shin, S. Lee, R. D. Abbott, J. H. Kim, S. Y. Lee, K. H. In, and K. Kimm
Respiratory Symptoms and Undiagnosed Airflow Obstruction in Middle-Aged Adults: The Korean Health and Genome Study
Chest, October 1, 2004; 126(4): 1234 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Hansell, J. Hollowell, R. McNiece, T. Nichols, and D. Strachan
Validity and interpretation of mortality, health service and survey data on COPD and asthma in England
Eur. Respir. J., February 1, 2003; 21(2): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Garcia-Aymerich, E Farrero, M A Felez, J Izquierdo, R M Marrades, and J M Anto
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study
Thorax, February 1, 2003; 58(2): 100 - 105.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Sunyer, X Basagana, J Belmonte, and J M Anto
Effect of nitrogen dioxide and ozone on the risk of dying in patients with severe asthma
Thorax, August 1, 2002; 57(8): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Earley and T. C. Resta
Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L86 - L93.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. D. SIN and J. V. TU
Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 580 - 584.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer
Epidemiology of chronic obstructive pulmonary disease
Eur. Respir. J., May 1, 2001; 17(5): 982 - 994.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. C. Resta, N. L. Kanagy, and B. R. Walker
Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression
Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L88 - L97.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. K. SILVERMAN, S. T. WEISS, J. M. DRAZEN, H. A. CHAPMAN, V. CAREY, E. J. CAMPBELL, P. DENISH, R. A. SILVERMAN, J. C. CELEDON, J. J. REILLY, et al.
Gender-Related Differences in Severe, Early-Onset Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2152 - 2158.
[Abstract] [Full Text]


Home page
ThoraxHome page
J. B Soriano, W. C Maier, P. Egger, G. Visick, B. Thakrar, J. Sykes, and N. B Pride
Recent trends in physician diagnosed COPD in women and men in the UK
Thorax, September 1, 2000; 55(9): 789 - 794.
[Abstract] [Full Text]


Home page
J. Epidemiol. Community HealthHome page
J. Garcia-Aymerich, A. Tobías, J. M. Antó, and J. Sunyer
Air pollution and mortality in a cohort of patients with chronic obstructive pulmonary disease: a time series analysis
J. Epidemiol. Community Health, January 1, 2000; 54(1): 73 - 74.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society